- Home
- TNON vs APM Comparison
TNON vs APM Comparison
Compare TNON & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNON
- APM
- Stock Information
- Founded
- TNON 2012
- APM 2010
- Country
- TNON United States
- APM United Kingdom
- Employees
- TNON N/A
- APM N/A
- Industry
- TNON Medical Specialities
- APM Biotechnology: Pharmaceutical Preparations
- Sector
- TNON Health Care
- APM Health Care
- Exchange
- TNON Nasdaq
- APM Nasdaq
- Market Cap
- TNON 6.9M
- APM 7.1M
- IPO Year
- TNON 2022
- APM 2018
- Fundamental
- Price
- TNON $0.99
- APM $0.94
- Analyst Decision
- TNON Strong Buy
- APM
- Analyst Count
- TNON 3
- APM 0
- Target Price
- TNON $11.67
- APM N/A
- AVG Volume (30 Days)
- TNON 174.9K
- APM 41.9K
- Earning Date
- TNON 08-12-2025
- APM 07-15-2025
- Dividend Yield
- TNON N/A
- APM N/A
- EPS Growth
- TNON N/A
- APM N/A
- EPS
- TNON N/A
- APM N/A
- Revenue
- TNON $3,284,000.00
- APM N/A
- Revenue This Year
- TNON $46.26
- APM N/A
- Revenue Next Year
- TNON $58.02
- APM N/A
- P/E Ratio
- TNON N/A
- APM N/A
- Revenue Growth
- TNON 2.18
- APM N/A
- 52 Week Low
- TNON $0.85
- APM $0.46
- 52 Week High
- TNON $15.79
- APM $7.49
- Technical
- Relative Strength Index (RSI)
- TNON 46.84
- APM 46.66
- Support Level
- TNON $0.88
- APM $0.91
- Resistance Level
- TNON $0.95
- APM $1.01
- Average True Range (ATR)
- TNON 0.06
- APM 0.06
- MACD
- TNON 0.02
- APM -0.02
- Stochastic Oscillator
- TNON 57.90
- APM 19.23
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.